Ask the doctor: For macular degeneration, which is better, Avastin or Lucentis?
Q. I have wet macular degeneration. I am trying to decide between Avastin and Lucentis. Which drug is better?
A. This is a complicated and very unsettled area. All of the professional organizations for ophthalmologists are struggling with it.
I should also mention right off the bat that I am on Genentech's scientific advisory committee. Genentech developed both Avastin and Lucentis. I am also the chair of the Phase 3 clinical trial of Eylea, another drug for wet macular degeneration, which I expect will be approved by the end of 2011.